IP Library Granted Patent US 7,089,059
Granted Patent B1
US 7,089,059 · App. 09/706,322 · Granted Aug 8, 2006

Predicting susceptibility to neurological dysfunction based on measured neural electrophysiology

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,089,059
App. No.
09/706,322
Granted
Aug 8, 2006
Kind
B1
Abstract

A system and method for determining and predicting a patient's susceptibility to neurological dysfunction based on measured electrophysiological parameters employs a self-contained implantable device with depth electrodes implanted in desired locations in the patient's brain. The patient's neurological tissue is stimulated to determine excitability and refractoriness (or inhibition period) parameters, which are employed to identify susceptibility to abnormal neurological activity, particularly epileptic seizures.

Claims (28)

1. A system for actively measuring at least one electrophysiological parameter of a region of a patient's brain and perform an action in response thereto, wherein the electrophysiological parameter comprises an excitability threshold of a neural pathway, the system comprising:

a stimulation subsystem operative to apply an electrical stimulation signal to the region of the patient's brain;

a sensing subsystem operative to detect an evoked response to the electrical stimulation signal;

a processor operative to calculate the electrophysiological parameter based on the evoked response and to initiate an action in response to the calculated electrophysiological parameter; and

a control module including the stimulation subsystem, the sensing subsystem, and the processor, wherein the control module has a biocompatible housing.

2. The system of claim 1 , wherein the housing is implanted in the head of the patient.

3. The system of claim 2 , wherein the housing is implanted intracranially.

4. The system of claim 1 , further comprising a stimulation lead having at least one stimulation electrode adapted to be implanted at a first location within the region of the patient's brain.

5. The system of claim 4 , further comprising a measurement lead having at least one measurement electrode adapted to be implanted at a second location within the region of the patient's brain.

6. The system of claim 1 , wherein the stimulation subsystem is further operative to provide therapeutic stimulation.

7. The system of claim 1 , wherein the stimulation subsystem is further operative to provide sensory stimulation.

8. A method for actively measuring an electrophysiological parameter of a region of a patient's brain, wherein the electrophysiological parameter comprises an excitability threshold of a neural pathway, the method comprising the steps of;

selecting a test value for the electrophysiological parameter;

performing a measurement using the test value of the electrophysiological parameter to receive a response; and

determining whether the response meets a criterion, and if not, adjusting the test value and repeating the testing and determining steps.

9. The method of claim 8 , wherein the performing step comprises the steps of;

applying an electrical stimulation pulse to a stimulation lead implanted in a first location in the region of the patient's brain; and

receiving a response signal with a measurement lead implanted in a second location in the region of the patient's brain.

10. The method of claim 9 , wherein the determining step comprises identifying an evoked response in the response signal.

11. The method of claim 9 , further comprising the steps of;

repeating the applying and receiving steps at least once;

averaging the response signals to produce an average response signal.

12. The method of claim 8 , wherein the adjusting step employs a linear search strategy.

13. The method of claim 8 , wherein the adjusting step employs a binary search strategy.

14. The method of claim 8 further comprising the step of calculating the electrophysiological parameter if the response meets the criterion.

15. The method of claim 14 , further comprising the step of performing an action in response to the calculated electrophysiological parameter.

16. The method of claim 15 , wherein the step of performing an action comprises applying therapeutic electrical stimulation to a location in the patient's brain.

17. The method of claim 15 , wherein the step of performing an action comprises providing a warning to the patient.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jun 4, 2025
From: CRG SERVICING LLC AS SUCCESSOR TO CAPITAL ROYALTY PARTNERS II L.P., CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P., AND PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: NEUROPACE INC.
Reel/Frame 071495/0800 →
SECURITY INTEREST Recorded Sep 25, 2020
From: NEUROPACE, INC.
To: CRG SERVICING LLC
Reel/Frame 053885/0932 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Nov 20, 2014
From: NEUROPACE, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 034410/0767 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2007
From: PLESS, BENJAMIN D.
To: NEUROPACE, INC.
Reel/Frame 019529/0466 →